Elicio Therapeutics, Inc. (ELTX)
1.92
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
1.92
0.00 (0.00%)
After-Hours: 20:00
Elicio Therapeutics Price to Book Value : 5.298 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 5.298 |
| October 01, 2026 | 5.298 |
| September 30, 2026 | 5.022 |
| September 29, 2026 | 5.077 |
| September 28, 2026 | 5.105 |
| September 25, 2026 | 5.077 |
| September 24, 2026 | 5.188 |
| September 23, 2026 | 5.160 |
| September 22, 2026 | 5.160 |
| September 21, 2026 | 5.271 |
| September 18, 2026 | 5.215 |
| September 17, 2026 | 5.146 |
| September 16, 2026 | 4.884 |
| September 15, 2026 | 5.491 |
| September 14, 2026 | 5.519 |
| September 11, 2026 | 5.657 |
| September 10, 2026 | 5.822 |
| September 09, 2026 | 6.016 |
| September 08, 2026 | 6.485 |
| September 04, 2026 | 6.650 |
| September 03, 2026 | 6.899 |
| September 02, 2026 | 7.037 |
| September 01, 2026 | 7.064 |
| August 31, 2026 | 7.451 |
| August 28, 2026 | 7.837 |
| Date | Value |
|---|---|
| August 27, 2026 | 8.278 |
| August 26, 2026 | 8.223 |
| August 25, 2026 | 8.306 |
| August 24, 2026 | 8.223 |
| August 21, 2026 | 8.389 |
| August 20, 2026 | 8.485 |
| August 19, 2026 | 8.637 |
| August 18, 2026 | 8.582 |
| August 17, 2026 | 8.334 |
| August 14, 2026 | 8.527 |
| August 13, 2026 | 8.692 |
| August 12, 2026 | 8.444 |
| August 11, 2026 | 8.361 |
| August 10, 2026 | 8.554 |
| August 07, 2026 | 8.803 |
| August 06, 2026 | 8.665 |
| August 05, 2026 | 8.803 |
| August 04, 2026 | 8.720 |
| August 03, 2026 | 7.892 |
| July 31, 2026 | 7.726 |
| July 30, 2026 | 8.03 |
| July 29, 2026 | 7.975 |
| July 28, 2026 | 8.140 |
| July 27, 2026 | 8.278 |
| July 24, 2026 | 8.278 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 18.64 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.426 |
| Curis, Inc. | 0.3335 |
Price to Book Value Related Metrics
| Price | 1.92 |
| Earnings Yield | -110.1% |
| Market Cap | 42.05M |